Misinterpretation of TPMT by a DTC genetic testing company. [electronic resource]
- Clinical pharmacology and therapeutics Jun 2014
- 598-600 p. digital
Publication Type: Journal Article
1532-6535
10.1038/clpt.2014.60 doi
Alleles Breast Neoplasms--enzymology Genetic Testing Methyltransferases--genetics Pharmacogenetics Polymorphism, Single Nucleotide--genetics Risk Assessment United States United States Food and Drug Administration